Publication:
The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism

dc.contributor.authorAsutay, Fatih
dc.contributor.authorAtalay, Yusuf
dc.contributor.authorAsutay, Hilal
dc.contributor.authorAcar, Ahmet Huseyin
dc.date.accessioned2020-10-22T15:51:56Z
dc.date.available2020-10-22T15:51:56Z
dc.date.issued2017-01-01T00:00:00Z
dc.description.abstractObjectives. Nocturnal bruxism can be managed by botulinum toxin (Botox (R)) in patients who have not responded to conservative treatment. The aim of this study was to evaluate the efficacy of botulinum toxin A (BTXA) in the treatment of nocturnal bruxism. Material and Methods. The retrospective study comprised 25 female patients, aged 23-55 years (mean 35.84 +/- 8.41 years). All patients received a single injection of BTXA in the right and left masseters. Evaluation was made by Visual Analogue Scale (VAS) values, complaint duration, onset of effect, and duration of effectiveness. Results. BTXA produced significant improvements in pain scores. Only 2 adverse events (8%) were recorded. Conclusion. BTX-A is effective in the treatment of nocturnal bruxism.
dc.identifier.citationAsutay F., Atalay Y., Asutay H., Acar A. H. , -The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism-, PAIN RESEARCH & MANAGEMENT, cilt.2017, 2017
dc.identifier.doi10.1155/2017/6264146
dc.identifier.pubmed28757802
dc.identifier.scopus85025070868
dc.identifier.urihttp://hdl.handle.net/20.500.12645/23527
dc.identifier.wosWOS:000404942800001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism
dc.typeArticle
dspace.entity.typePublication
local.avesis.id3ce82279-a28b-47d0-9438-7095a64996cb
local.publication.isinternational1
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
6264146.pdf
Size:
1.3 MB
Format:
Adobe Portable Document Format
Description: